We are live on ! Find out more
TSVT

2seventy bio
TSVT

Delisted

TSVT was delisted on the 13th of May, 2025.

Back to rankings

149 hedge funds and large institutions have $505M invested in 2seventy bio in 2023 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 61 increasing their positions, 30 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

184% more call options, than puts

Call options by funds: $1.16M | Put options by funds: $407K

103% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 30

14% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 22

2% more funds holding

Funds holding: 146 → 149 (+3)

1% less capital invested

Capital invested by funds: $508M → $505M (-$3.26M)

50% less funds holding in top 10

Funds holding in top 10: 4 → 2 (-2)

Holders
149
Holders Change
+3
Holders Change %
+2.05%
% of All Funds
2.34%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
25
Increased
61
Reduced
30
Closed
22
Calls
$1.16M
Puts
$407K
Net Calls
+$748K
Net Calls Change
+$456K

Top Buyers

Rank Fund Capital Flow
1
APM
Avidity Partners Management
Texas
+$14.2M
2
KCM
Kynam Capital Management
New Jersey
+$12.2M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$11.3M
4
BlackRock
BlackRock
New York
+$10.3M
5
Millennium Management
Millennium Management
New York
+$10.1M

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$22.9M
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$14.7M
3
ITP
Iron Triangle Partners
Connecticut
-$8.86M
4
NM
Newtyn Management
New York
-$8.12M
5
AG
Artal Group
Luxembourg
-$7.65M
Name Holding Trade Value Shares
Change 		Change in
Stake
S
126
SignatureFD
Georgia
$1.71K +$1.5K +142 +526%
LC
127
Lindbrook Capital
California
$1.66K +$1.74K +164 New
CCA
128
Column Capital Advisors
Indiana
$1.42K – – –
PP
129
PFS Partners
New Jersey
$1.14K – – –
SPIA
130
Steward Partners Investment Advisory
New York
$1.07K – – –
CAL
131
Capital Analysts LLC
Pennsylvania
$1K +$1.06K +100 New
HWM
132
HighMark Wealth Management
Minnesota
$769 – – –
BC
133
Barrett & Company
Rhode Island
$668 – – –
Northwestern Mutual Wealth Management
134
Northwestern Mutual Wealth Management
Wisconsin
$587 -$773 -73 -56%
Allspring Global Investments
135
Allspring Global Investments
North Carolina
$516 -$1.62K -153 -75%
Nisa Investment Advisors
136
Nisa Investment Advisors
Missouri
$435 +$32 +3 +8%
BWAM
137
Boyd Watterson Asset Management
Ohio
$415 – – –
TC
138
Truvestments Capital
Florida
$415 – – –
BCWM
139
Bartlett & Co Wealth Management
Ohio
$334 – – –
PFBT
140
Parkside Financial Bank & Trust
Missouri
$334 – – –
PA
141
Parallel Advisors
California
$334 +$318 +30 +1,000%
FFA
142
Fairfield Financial Advisors
Massachusetts
$202 – – –
DJSG
143
D.J. St. Germain
Massachusetts
$192 +$201 +19 New
GRP
144
Global Retirement Partners
California
$152 – – –
SA
145
SRH Advisors
Kansas
$61 – – –
TFM
146
TFC Financial Management
Massachusetts
$41 – – –
FGAM
147
Financial Gravity Asset Management
Texas
$14 +$106 +10 New
LSA
148
Leonteq Securities AG
Switzerland
$10 – – –
Balyasny Asset Management
149
Balyasny Asset Management
Illinois
– -$14.7M -1,437,302 Closed
ITP
150
Iron Triangle Partners
Connecticut
– -$8.86M -868,939 Closed
3 4 5
6
7

TSVT Hedge Fund Activity: Q2 2023 in Review

149 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in 2seventy bio (TSVT) for Q2 2023, worth a combined $505M — down 0.64% from $508M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new TSVT positions and 22 closed out — a net gain of 3 holders — while 61 added to existing stakes and 30 trimmed.

The largest buyer was Avidity Partners Management, opening a new position worth an estimated $14.2M. The largest seller was Citadel Advisors, cutting an estimated $22.9M.

  • 149 institutional investors held 2seventy bio (TSVT) as of Q2 2023, up from 146 in Q1 2023.
  • Funds reported $505M of 2seventy bio stock for Q2 2023, down 0.64% quarter-over-quarter.
  • 25 funds opened new 2seventy bio positions in Q2 2023 and 22 closed out, a net change of +3 holders.
  • The largest 2seventy bio buyer in Q2 2023 was Avidity Partners Management, an estimated $14.2M added.
  • The largest 2seventy bio seller in Q2 2023 was Citadel Advisors, an estimated $22.9M sold.

Based on aggregated 13F filings for Q2 2023.